| Literature DB >> 26200715 |
J P B Gonçalves1, G Lucchetti2, P R Menezes3, H Vallada1.
Abstract
BACKGROUND: Despite the extensive literature assessing associations between religiosity/spirituality and health, few studies have investigated the clinical applicability of this evidence. The purpose of this paper was to assess the impact of religious/spiritual interventions (RSI) through randomized clinical trials (RCTs).Entities:
Keywords: Clinical care; clinical trials; meta-analyses; religiosity; spirituality
Mesh:
Year: 2015 PMID: 26200715 PMCID: PMC4595860 DOI: 10.1017/S0033291715001166
Source DB: PubMed Journal: Psychol Med ISSN: 0033-2917 Impact factor: 7.723
Fig. 1.Flowchart of the selected studies following PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines.
Characteristics of studies
| Author (year) | Participants | Sample size | Scale | Type of intervention | Number of sessions/duration of sessions, min | Follow-up, months | Results compared with control groups |
|---|---|---|---|---|---|---|---|
| Bay | Cardiac presurgical | 170 | HADS, S S/R | Pastoral services | 4/44 | 1 to 6 | N/+ |
| Bormann | HIV+ | 93 | Q-LES-Q, PSS, STAI, CES-D, S S/R | Meditation | 5/90 | 1 to 6 | N/N/+/+/+ |
| Bormann | Post-traumatic stress disorder | 29 | PTSD, Q-LES-Q, S S/R | Meditation | 6/90 | 1 to 6 | +/+/+ |
| Bormann & Carrico ( | HIV+ | 93 | STAI, S S/R | Meditation | 5/90 | 1 to 6 | +/+ |
| Bowland | Post-traumatic stress disorder | 43 | GDS, BAI, S S/R | Therapy | 11/90 | 1 to 6 | +/+/N |
| Breitbart | Cancer | 90 | HADS, S S/R | Therapy | 8/90 | 1 to 6 | N/+ |
| Breitbart | Cancer | 120 | MQOL, HADS, S S/R | Therapy | 7/60 | 1 to 6 | +/N/N |
| Djuric | Cancer survivors | 24 | Weight, 7D-PAR, CES-D, S S/R | Therapy | 13/? | >6 | +/N/+/+ |
| Hosseini | Cardiac presurgical | 70 | HAS | Pastoral services | 5/45–60 | <1 | + |
| Huguelet | Schizophrenia | 84 | PNSS, S S/R | Therapy | 1+n/? | 1 to 6 | N/N |
| Kelly | Drug users | 774 | Form90-D, S S/R | Therapy | 12/60 | >6 | +/+ |
| Koszycki | Generalized anxiety disorder | 23 | HAS, PSWQ, BAI, BDI, S S/R | Therapy | 12/50 | 1 to 6 | +/+/N/N/+ |
| Lloyd-Williams | Cancer | 100 | BEDS, S S/R | Therapy | 8/? | 1 to 6 | N/+ |
| McCauley | Chronic pain | 100 | Pain, MOOD, S S/R | Audiovisual sources | 5/28 | 1 to 6 | N/N/N |
| Miller | Terminal patients | 51 | BDI, STAI, S S/R | Therapy | 12/75 | >6 | N/N/N |
| Miller | Drug users | 64 | Form90-D, BDI, STAI, S S/R | Audiovisual sources | 12/? | <1 | −/−/−/N |
| Moritz | Emotional stress and depression | 165 | POMS, SF-36, S S/R | Audiovisual sources | 8/90 | 1 to 6 | +/+ |
| Oman | Healthy | 58 | PSS, MBI | Meditation | 5/90 | 1 to 6 | +/+ |
| Oman | Healthy | 58 | PSS, S S/R | Meditation | 5/90 | 1 to 6 | +/+ |
| Rickhi | Depression | 84 | HAM-D | Audiovisual sources | 8/90 | 1 to 6 | + |
| Rosmarin | Generalized anxiety disorder | 261 | PSWQ, CES-D, S S/R | Audiovisual sources | 14/30 | >6 | +/N/+ |
| Wachholtz & Pargament ( | Healthy | 84 | STAI, Pain, S S/R | Meditation | 14/20 | 1 to 6 | +/N/+ |
| Wachholtz & Pargament ( | Headache | 83 | ID-MS, Pain, STAI, CES-D, MSQFS, S S/R | Meditation | 30/20 | 1 to 6 | +/N/N/N/+ |
HADS, Hospital Anxiety and Depression Scale; S R/S, different scales of religiosity/spirituality; N, no difference between groups; +, positive effect; HIV+, human immunodeficiency virus-positive; Q-LES-Q, Quality of Life Enjoyment and Satisfaction Questionnaire; PSS, Perceived Stress Scale; STAI, Spielberger's State Anxiety Inventory; CES-D, Center for Epidemiological Studies Depression Scale; PTSD, Post-Traumatic Stress Disorder Scale; GDS, Geriatric Depression Scale; BAI, Beck Anxiety Inventory; MQOL, McGill Quality of Life Questionnaire; 7D-PAR, Seven-Day Physical Activity Recall; HAS, Hamilton Anxiety Scale; PNSS, Positive and Negative Syndrome Scale; Form90-D, alcohol questionnaire; PSWQ, Penn State Worry Questionnaire; BDI, Beck Depression Inventory; BEDS, Brief Edinburgh Depression Scale; MOOD, depressive symptoms; −, negative effect; POMS, Profile of Mood States; SF-36, Medical Outcomes Study 36; MBI, Maslach Burnout Inventory; HAM-D, Hamilton Depression Scale; ID-MS, ID Migraine Screener; MSQFS, Migraine Specific Quality of Life Scale.
Fig. 2.Forest plot of effect sizes for anxiety symptoms. SD, Standard deviation; IV, inverse variance; CI, confidence interval; df, degrees of freedom.
Fig. 3.Forest plot of effect sizes for depressive symptoms. SD, Standard deviation; IV, inverse variance; CI, confidence interval; df, degrees of freedom.
Description of the Cochrane Back Review Scale of methodological quality
| Author (year) | A | B | C | D | E | F | G | H | I | J | K | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bay | + | + | + | − | − | − | + | + | + | + | − | 7 |
| Bormann | + | + | + | − | − | − | + | + | + | + | + | 8 |
| Bormann | + | + | + | − | − | ? | + | + | + | + | ? | 7 |
| Bormann & Carrico ( | + | + | + | − | − | − | + | + | + | + | + | 8 |
| Bowland | + | + | + | − | − | + | − | + | + | + | + | 8 |
| Breitbart | + | + | + | − | − | ? | + | + | + | + | − | 7 |
| Breitbart | + | + | ? | − | − | ? | + | + | + | + | − | 6 |
| Djuric | + | + | + | − | − | ? | + | + | + | + | − | 7 |
| Hosseini | + | + | + | − | − | ? | − | − | + | + | − | 5 |
| Huguelet | + | + | + | − | − | − | + | + | + | + | − | 7 |
| Kelly | + | + | + | − | − | + | + | + | − | + | + | 8 |
| Koszycki | + | + | + | − | − | ? | + | + | + | + | + | 8 |
| Lloyd-Williams | + | + | − | − | − | ? | ? | + | − | + | ? | 4 |
| McCauley | + | + | + | − | − | + | + | + | + | + | + | 9 |
| Miller | + | − | + | − | − | − | + | + | + | + | − | 6 |
| Miller | + | − | + | − | − | − | − | + | + | + | + | 6 |
| Moritz | + | + | + | − | − | ? | − | + | + | + | + | 7 |
| Oman | + | + | + | − | − | − | + | + | + | + | + | 8 |
| Oman | + | + | + | − | − | − | + | + | + | + | + | 8 |
| Rickhi | + | + | + | − | − | + | + | + | − | + | + | 8 |
| Rosmarin | + | + | + | − | − | ? | + | + | − | + | + | 7 |
| Wachholtz & Pargament ( | + | + | + | − | − | − | + | + | + | + | + | 8 |
| Wachholtz & Pargament ( | + | + | + | − | − | ? | + | + | + | + | + | 8 |
A, Randomization method; B, allocation concealed; C, similar baseline; D, patient blinded; E, provider blinded; F, assessor blinded; G, co-intervention avoided; H, acceptable compliance; I, acceptable drop-out; J, timing of outcome assessment similar; K, intention-to-treat analysis.